8,000-Person study seeks early warning signs for hormone and metabolic disorders

NCT ID NCT07512609

Recruiting now Knowledge-focused Sponsor: Qifu Li Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will enroll 8,000 adults undergoing routine health checkups. Researchers will measure hormone levels and collect health data to understand how environment, genes, and proteins interact in conditions like high blood pressure and diabetes. The goal is to create an early warning system and identify new targets for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early detection tools and new treatment targets for conditions like high blood pressure and diabetes.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any therapy, and results may take years to translate into practical medical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus endocrine system disorder hypertensive disorder metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS ENDOCRINE DISEASE HYPERTENSION METABOLIC DISORDERS

Contacts and locations

Locations

The First Affiliated Hospital of Chongqing Medical University
RECRUITING

Chongqing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.